Skip to content

MicroRNA combined with other indicators in the diagnosis of pulmonary hypertension

MicroRNA combined with other indicators in the diagnosis of pulmonary hypertension

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042183
Enrollment
Unknown
Registered
2021-01-15
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary hypertation

Interventions

Index test:miRNAs&#32
(miR-17-5?miR-100?miR-27a?miR-20R)

Sponsors

The First Hospital of Shanxi Medical Universityy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria of pulmonary hypertension group: in accordance with the Chinese guidelines for the diagnosis and treatment of pulmonary hypertension issued by the pulmonary vascular disease group of Chinese Medical Association in 2018. Diagnostic criteria: mean pulmonary artery pressure (mPAP) >= 25 mmHg measured at sea level, at rest and right heart catheterization. Inclusion criteria of healthy control group: complete routine examination, no history of chronic diseases such as chronic bronchitis, no history of severe cardiopulmonary disease, tumor, etc.

Exclusion criteria

Exclusion criteria: Patients with severe infection, ischemic heart disease, malignant tumor, liver and kidney disease, other major diseases and mental disorders were excluded.

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactYiwei Shi

The First Hospital of Shanxi Medical University

chinasyw225@163.com+86 13934568990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026